Successful marketing of medical technology and pharmaceutical products depends on accurate, actionable insights that can govern every stage of the development process. Guidehouse’s proven, proprietary methodologies deliver data-driven critical thinking and analysis that can generate scientific validation that help clients invest the right amount of resources at the right time.
Through comprehensive, fact-based research and analysis, we determine the realizable market potential and inform every stage of product development, including clinical trials, fundraising, commercialization, marketing and market development investments, partnerships, acquisitions, and exits.
Our Science of Market Development methodology (pioneered by Dymedex Consulting prior to its acquisition by Guidehouse), utilizes 14 critical factors to identify, assess, and reduce market risk and promote the commercial success of ventures. This rigorous process uncovers opportunities, avoids costly pitfalls, increases value, and reduces time and investment.
Our solutions align across the client’s organization, achieve key milestones, help secure funding and develop powerful, go-to-market strategies. Our solutions include:
- Strategic Market Assessment (SMA)
- Market development, entry and launch strategy
- Clinical development strategy
- Global geographic prioritization
- Portfolio management/product planning and development
- Revenue and growth forecasting
Latest From Strategic Market Development
April 2, 2020 Case StudyGuidehouse Insights Define New Digital Technology Market and Align Investments for $350M OpportunityRoss Meisner & Mike Fix
January 29, 2020 Case StudyGuidehouse Helps Medtech Startup Navigate a Complex Market, Leading to Substantial Acquisition
May 14, 2019 Case StudyGuidehouse's Proprietary Approach Resets the True Opportunity Size for a Blockbuster Drug's New Indication